Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ROBENGATOPE

ROSE BENGAL SODIUM I-131

Standard Dose
0.5mCi/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ROBENGATOPE is listed in Drugs@FDA under application 016224 (NDA).

Marketing status: Discontinued Active ingredient ROSE BENGAL SODIUM I-131 Form and strength INJECTABLE;INJECTION - 0.5mCi/VIAL Sponsor BRACCO Submission history Latest submission status date: 2009-03-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview ROBENGATOPE is listed in Drugs@FDA under application 016224 (NDA). Marketing status: Discontinued Active ingredient ROSE BENGAL SODIUM I-131 Form and strength INJECTABLE;INJECTION - 0.5mCi/VIAL Sponsor BRACCO Submission history Latest submission status date: 2009-03-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
ROBENGATOPE (ROSE BENGAL SODIUM I-131) | Drug Monograph | MedicHelpline